Pharma & Healthcare
Global Amlodipine Besylate Market Research Report 2024
- Jan 18, 24
- ID: 3179
- Pages: 115
- Figures: 248
- Views: 33
Amlodipine Besylate is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension and Coronary Artery Disease.
The global Amlodipine Besylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine Besylate include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate.
Report Scope
The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets
Segment by Application
High Blood Pressure
Heart Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Amlodipine Besylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amlodipine Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amlodipine Besylate include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma and Upsher-Smith Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate.
Report Scope
The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amlodipine Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mylan
Dr. Reddy's Laboratories
Apotex
Teva Pharmaceutical
Cipla
Hikma Pharmaceuticals
Strides Pharma
Upsher-Smith Laboratories
InvaGen Pharmaceuticals
Sun Pharmaceutical
Aurobindo Pharma
Lupin Pharmaceuticals
Zydus Pharmaceuticals
Oxford Pharm
Wockhardt
Epic Pharma
CR Pharmaceutical
Alkem Laboratories
MACLEODS
Segment by Type
2.5mg Tablets
5mg Tablets
10mg Tablets
Segment by Application
High Blood Pressure
Heart Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amlodipine Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Amlodipine Besylate Market Overview
1.1 Product Overview and Scope of Amlodipine Besylate
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Market Value Comparison by Type (2024-2030)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Global Amlodipine Besylate Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Revenue 2019-2030
1.4.2 Global Amlodipine Besylate Sales 2019-2030
1.4.3 Global Amlodipine Besylate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Besylate Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Besylate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
2.7 Amlodipine Besylate Market Competitive Situation and Trends
2.7.1 Amlodipine Besylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Players Market Share by Revenue
2.7.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Besylate Global Amlodipine Besylate Sales by Region: 2019-2030
3.2.1 Global Amlodipine Besylate Sales by Region: 2019-2024
3.2.2 Global Amlodipine Besylate Sales by Region: 2025-2030
3.3 Global Amlodipine Besylate Global Amlodipine Besylate Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Besylate Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Besylate Revenue by Region: 2025-2030
3.4 North America Amlodipine Besylate Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Besylate Sales by Country (2019-2030)
3.4.3 North America Amlodipine Besylate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amlodipine Besylate Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Besylate Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Besylate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amlodipine Besylate Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Besylate Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Besylate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Sales by Type (2019-2030)
4.1.1 Global Amlodipine Besylate Sales by Type (2019-2024)
4.1.2 Global Amlodipine Besylate Sales by Type (2025-2030)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Besylate Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Besylate Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Besylate Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Besylate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Besylate Sales by Application (2019-2030)
5.1.1 Global Amlodipine Besylate Sales by Application (2019-2024)
5.1.2 Global Amlodipine Besylate Sales by Application (2025-2030)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Besylate Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Besylate Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Besylate Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Besylate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Amlodipine Besylate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Amlodipine Besylate Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Amlodipine Besylate Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Amlodipine Besylate Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Strides Pharma
6.8.1 Strides Pharma Corporation Information
6.8.2 Strides Pharma Description and Business Overview
6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Strides Pharma Amlodipine Besylate Product Portfolio
6.8.5 Strides Pharma Recent Developments/Updates
6.9 Upsher-Smith Laboratories
6.9.1 Upsher-Smith Laboratories Corporation Information
6.9.2 Upsher-Smith Laboratories Description and Business Overview
6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
6.9.5 Upsher-Smith Laboratories Recent Developments/Updates
6.10 InvaGen Pharmaceuticals
6.10.1 InvaGen Pharmaceuticals Corporation Information
6.10.2 InvaGen Pharmaceuticals Description and Business Overview
6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
6.10.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Amlodipine Besylate Description and Business Overview
6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Amlodipine Besylate Description and Business Overview
6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Lupin Pharmaceuticals
6.13.1 Lupin Pharmaceuticals Corporation Information
6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
6.13.5 Lupin Pharmaceuticals Recent Developments/Updates
6.14 Zydus Pharmaceuticals
6.14.1 Zydus Pharmaceuticals Corporation Information
6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
6.14.5 Zydus Pharmaceuticals Recent Developments/Updates
6.15 Oxford Pharm
6.15.1 Oxford Pharm Corporation Information
6.15.2 Oxford Pharm Amlodipine Besylate Description and Business Overview
6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Oxford Pharm Amlodipine Besylate Product Portfolio
6.15.5 Oxford Pharm Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Amlodipine Besylate Description and Business Overview
6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wockhardt Amlodipine Besylate Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Epic Pharma
6.17.1 Epic Pharma Corporation Information
6.17.2 Epic Pharma Amlodipine Besylate Description and Business Overview
6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Epic Pharma Amlodipine Besylate Product Portfolio
6.17.5 Epic Pharma Recent Developments/Updates
6.18 CR Pharmaceutical
6.18.1 CR Pharmaceutical Corporation Information
6.18.2 CR Pharmaceutical Amlodipine Besylate Description and Business Overview
6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.18.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
6.18.5 CR Pharmaceutical Recent Developments/Updates
6.19 Alkem Laboratories
6.19.1 Alkem Laboratories Corporation Information
6.19.2 Alkem Laboratories Amlodipine Besylate Description and Business Overview
6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
6.19.5 Alkem Laboratories Recent Developments/Updates
6.20 MACLEODS
6.20.1 MACLEODS Corporation Information
6.20.2 MACLEODS Amlodipine Besylate Description and Business Overview
6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.20.4 MACLEODS Amlodipine Besylate Product Portfolio
6.20.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Industry Chain Analysis
7.2 Amlodipine Besylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Production Mode & Process
7.4 Amlodipine Besylate Sales and Marketing
7.4.1 Amlodipine Besylate Sales Channels
7.4.2 Amlodipine Besylate Distributors
7.5 Amlodipine Besylate Customers
8 Amlodipine Besylate Market Dynamics
8.1 Amlodipine Besylate Industry Trends
8.2 Amlodipine Besylate Market Drivers
8.3 Amlodipine Besylate Market Challenges
8.4 Amlodipine Besylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Amlodipine Besylate
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Market Value Comparison by Type (2024-2030)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Global Amlodipine Besylate Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Revenue 2019-2030
1.4.2 Global Amlodipine Besylate Sales 2019-2030
1.4.3 Global Amlodipine Besylate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Besylate Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Besylate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
2.7 Amlodipine Besylate Market Competitive Situation and Trends
2.7.1 Amlodipine Besylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Players Market Share by Revenue
2.7.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Besylate Global Amlodipine Besylate Sales by Region: 2019-2030
3.2.1 Global Amlodipine Besylate Sales by Region: 2019-2024
3.2.2 Global Amlodipine Besylate Sales by Region: 2025-2030
3.3 Global Amlodipine Besylate Global Amlodipine Besylate Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Besylate Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Besylate Revenue by Region: 2025-2030
3.4 North America Amlodipine Besylate Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Besylate Sales by Country (2019-2030)
3.4.3 North America Amlodipine Besylate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amlodipine Besylate Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Besylate Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Besylate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amlodipine Besylate Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Besylate Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Besylate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Sales by Type (2019-2030)
4.1.1 Global Amlodipine Besylate Sales by Type (2019-2024)
4.1.2 Global Amlodipine Besylate Sales by Type (2025-2030)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Besylate Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Besylate Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Besylate Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Besylate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Besylate Sales by Application (2019-2030)
5.1.1 Global Amlodipine Besylate Sales by Application (2019-2024)
5.1.2 Global Amlodipine Besylate Sales by Application (2025-2030)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Besylate Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Besylate Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Besylate Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Besylate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Amlodipine Besylate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Amlodipine Besylate Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Amlodipine Besylate Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Amlodipine Besylate Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Strides Pharma
6.8.1 Strides Pharma Corporation Information
6.8.2 Strides Pharma Description and Business Overview
6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Strides Pharma Amlodipine Besylate Product Portfolio
6.8.5 Strides Pharma Recent Developments/Updates
6.9 Upsher-Smith Laboratories
6.9.1 Upsher-Smith Laboratories Corporation Information
6.9.2 Upsher-Smith Laboratories Description and Business Overview
6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
6.9.5 Upsher-Smith Laboratories Recent Developments/Updates
6.10 InvaGen Pharmaceuticals
6.10.1 InvaGen Pharmaceuticals Corporation Information
6.10.2 InvaGen Pharmaceuticals Description and Business Overview
6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
6.10.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Amlodipine Besylate Description and Business Overview
6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Amlodipine Besylate Description and Business Overview
6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Lupin Pharmaceuticals
6.13.1 Lupin Pharmaceuticals Corporation Information
6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
6.13.5 Lupin Pharmaceuticals Recent Developments/Updates
6.14 Zydus Pharmaceuticals
6.14.1 Zydus Pharmaceuticals Corporation Information
6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
6.14.5 Zydus Pharmaceuticals Recent Developments/Updates
6.15 Oxford Pharm
6.15.1 Oxford Pharm Corporation Information
6.15.2 Oxford Pharm Amlodipine Besylate Description and Business Overview
6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Oxford Pharm Amlodipine Besylate Product Portfolio
6.15.5 Oxford Pharm Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Amlodipine Besylate Description and Business Overview
6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wockhardt Amlodipine Besylate Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Epic Pharma
6.17.1 Epic Pharma Corporation Information
6.17.2 Epic Pharma Amlodipine Besylate Description and Business Overview
6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Epic Pharma Amlodipine Besylate Product Portfolio
6.17.5 Epic Pharma Recent Developments/Updates
6.18 CR Pharmaceutical
6.18.1 CR Pharmaceutical Corporation Information
6.18.2 CR Pharmaceutical Amlodipine Besylate Description and Business Overview
6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.18.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
6.18.5 CR Pharmaceutical Recent Developments/Updates
6.19 Alkem Laboratories
6.19.1 Alkem Laboratories Corporation Information
6.19.2 Alkem Laboratories Amlodipine Besylate Description and Business Overview
6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
6.19.5 Alkem Laboratories Recent Developments/Updates
6.20 MACLEODS
6.20.1 MACLEODS Corporation Information
6.20.2 MACLEODS Amlodipine Besylate Description and Business Overview
6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.20.4 MACLEODS Amlodipine Besylate Product Portfolio
6.20.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Industry Chain Analysis
7.2 Amlodipine Besylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Production Mode & Process
7.4 Amlodipine Besylate Sales and Marketing
7.4.1 Amlodipine Besylate Sales Channels
7.4.2 Amlodipine Besylate Distributors
7.5 Amlodipine Besylate Customers
8 Amlodipine Besylate Market Dynamics
8.1 Amlodipine Besylate Industry Trends
8.2 Amlodipine Besylate Market Drivers
8.3 Amlodipine Besylate Market Challenges
8.4 Amlodipine Besylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amlodipine Besylate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amlodipine Besylate Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amlodipine Besylate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amlodipine Besylate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amlodipine Besylate Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amlodipine Besylate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 18. Global Amlodipine Besylate Sales Market Share by Region (2019-2024)
Table 19. Global Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 20. Global Amlodipine Besylate Sales Market Share by Region (2025-2030)
Table 21. Global Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amlodipine Besylate Revenue Market Share by Region (2019-2024)
Table 23. Global Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amlodipine Besylate Revenue Market Share by Region (2025-2030)
Table 25. North America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 27. North America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 28. North America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amlodipine Besylate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amlodipine Besylate Sales (K Units) by Type (2019-2024)
Table 51. Global Amlodipine Besylate Sales (K Units) by Type (2025-2030)
Table 52. Global Amlodipine Besylate Sales Market Share by Type (2019-2024)
Table 53. Global Amlodipine Besylate Sales Market Share by Type (2025-2030)
Table 54. Global Amlodipine Besylate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amlodipine Besylate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amlodipine Besylate Revenue Market Share by Type (2019-2024)
Table 57. Global Amlodipine Besylate Revenue Market Share by Type (2025-2030)
Table 58. Global Amlodipine Besylate Price (USD/Unit) by Type (2019-2024)
Table 59. Global Amlodipine Besylate Price (USD/Unit) by Type (2025-2030)
Table 60. Global Amlodipine Besylate Sales (K Units) by Application (2019-2024)
Table 61. Global Amlodipine Besylate Sales (K Units) by Application (2025-2030)
Table 62. Global Amlodipine Besylate Sales Market Share by Application (2019-2024)
Table 63. Global Amlodipine Besylate Sales Market Share by Application (2025-2030)
Table 64. Global Amlodipine Besylate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amlodipine Besylate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amlodipine Besylate Revenue Market Share by Application (2019-2024)
Table 67. Global Amlodipine Besylate Revenue Market Share by Application (2025-2030)
Table 68. Global Amlodipine Besylate Price (USD/Unit) by Application (2019-2024)
Table 69. Global Amlodipine Besylate Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Amlodipine Besylate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Amlodipine Besylate Product
Table 79. Mylan Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Amlodipine Besylate Product
Table 89. Apotex Recent Developments/Updates
Table 90. Teva Pharmaceutical Corporation Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Amlodipine Besylate Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Amlodipine Besylate Product
Table 99. Cipla Recent Developments/Updates
Table 100. Hikma Pharmaceuticals Corporation Information
Table 101. Hikma Pharmaceuticals Description and Business Overview
Table 102. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 104. Hikma Pharmaceuticals Recent Developments/Updates
Table 105. Strides Pharma Corporation Information
Table 106. Strides Pharma Description and Business Overview
Table 107. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Strides Pharma Amlodipine Besylate Product
Table 109. Strides Pharma Recent Developments/Updates
Table 110. Upsher-Smith Laboratories Corporation Information
Table 111. Upsher-Smith Laboratories Description and Business Overview
Table 112. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 114. Upsher-Smith Laboratories Recent Developments/Updates
Table 115. InvaGen Pharmaceuticals Corporation Information
Table 116. InvaGen Pharmaceuticals Description and Business Overview
Table 117. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 119. InvaGen Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sun Pharmaceutical Amlodipine Besylate Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Aurobindo Pharma Amlodipine Besylate Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Lupin Pharmaceuticals Corporation Information
Table 131. Lupin Pharmaceuticals Description and Business Overview
Table 132. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 134. Lupin Pharmaceuticals Recent Developments/Updates
Table 135. Zydus Pharmaceuticals Corporation Information
Table 136. Zydus Pharmaceuticals Description and Business Overview
Table 137. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 139. Zydus Pharmaceuticals Recent Developments/Updates
Table 140. Oxford Pharm Corporation Information
Table 141. Oxford Pharm Description and Business Overview
Table 142. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Oxford Pharm Amlodipine Besylate Product
Table 144. Oxford Pharm Recent Developments/Updates
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Wockhardt Amlodipine Besylate Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Epic Pharma Corporation Information
Table 151. Epic Pharma Description and Business Overview
Table 152. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Epic Pharma Amlodipine Besylate Product
Table 154. Epic Pharma Recent Developments/Updates
Table 155. CR Pharmaceutical Corporation Information
Table 156. CR Pharmaceutical Description and Business Overview
Table 157. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. CR Pharmaceutical Amlodipine Besylate Product
Table 159. CR Pharmaceutical Recent Developments/Updates
Table 160. Alkem Laboratories Corporation Information
Table 161. Alkem Laboratories Description and Business Overview
Table 162. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Alkem Laboratories Amlodipine Besylate Product
Table 164. Alkem Laboratories Recent Developments/Updates
Table 165. MACLEODS Corporation Information
Table 166. MACLEODS Description and Business Overview
Table 167. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. MACLEODS Amlodipine Besylate Product
Table 169. MACLEODS Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Amlodipine Besylate Distributors List
Table 173. Amlodipine Besylate Customers List
Table 174. Amlodipine Besylate Market Trends
Table 175. Amlodipine Besylate Market Drivers
Table 176. Amlodipine Besylate Market Challenges
Table 177. Amlodipine Besylate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine Besylate
Figure 2. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amlodipine Besylate Market Share by Type in 2023 & 2030
Figure 4. 2.5mg Tablets Product Picture
Figure 5. 5mg Tablets Product Picture
Figure 6. 10mg Tablets Product Picture
Figure 7. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amlodipine Besylate Market Share by Application in 2023 & 2030
Figure 9. High Blood Pressure
Figure 10. Heart Disease
Figure 11. Global Amlodipine Besylate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Amlodipine Besylate Market Size (2019-2030) & (US$ Million)
Figure 13. Global Amlodipine Besylate Sales (2019-2030) & (K Units)
Figure 14. Global Amlodipine Besylate Average Price (USD/Unit) & (2019-2030)
Figure 15. Amlodipine Besylate Report Years Considered
Figure 16. Amlodipine Besylate Sales Share by Manufacturers in 2023
Figure 17. Global Amlodipine Besylate Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Amlodipine Besylate Players: Market Share by Revenue in 2023
Figure 19. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 22. North America Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 26. Europe Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 27. Germany Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2019-2030)
Figure 34. China Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 45. Latin America Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Amlodipine Besylate by Type (2019-2030)
Figure 55. Global Revenue Market Share of Amlodipine Besylate by Type (2019-2030)
Figure 56. Global Amlodipine Besylate Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Amlodipine Besylate by Application (2019-2030)
Figure 58. Global Revenue Market Share of Amlodipine Besylate by Application (2019-2030)
Figure 59. Global Amlodipine Besylate Price (USD/Unit) by Application (2019-2030)
Figure 60. Amlodipine Besylate Value Chain
Figure 61. Amlodipine Besylate Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amlodipine Besylate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amlodipine Besylate Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amlodipine Besylate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amlodipine Besylate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amlodipine Besylate Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amlodipine Besylate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 18. Global Amlodipine Besylate Sales Market Share by Region (2019-2024)
Table 19. Global Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 20. Global Amlodipine Besylate Sales Market Share by Region (2025-2030)
Table 21. Global Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amlodipine Besylate Revenue Market Share by Region (2019-2024)
Table 23. Global Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amlodipine Besylate Revenue Market Share by Region (2025-2030)
Table 25. North America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 27. North America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 28. North America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amlodipine Besylate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amlodipine Besylate Sales (K Units) by Type (2019-2024)
Table 51. Global Amlodipine Besylate Sales (K Units) by Type (2025-2030)
Table 52. Global Amlodipine Besylate Sales Market Share by Type (2019-2024)
Table 53. Global Amlodipine Besylate Sales Market Share by Type (2025-2030)
Table 54. Global Amlodipine Besylate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amlodipine Besylate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amlodipine Besylate Revenue Market Share by Type (2019-2024)
Table 57. Global Amlodipine Besylate Revenue Market Share by Type (2025-2030)
Table 58. Global Amlodipine Besylate Price (USD/Unit) by Type (2019-2024)
Table 59. Global Amlodipine Besylate Price (USD/Unit) by Type (2025-2030)
Table 60. Global Amlodipine Besylate Sales (K Units) by Application (2019-2024)
Table 61. Global Amlodipine Besylate Sales (K Units) by Application (2025-2030)
Table 62. Global Amlodipine Besylate Sales Market Share by Application (2019-2024)
Table 63. Global Amlodipine Besylate Sales Market Share by Application (2025-2030)
Table 64. Global Amlodipine Besylate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amlodipine Besylate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amlodipine Besylate Revenue Market Share by Application (2019-2024)
Table 67. Global Amlodipine Besylate Revenue Market Share by Application (2025-2030)
Table 68. Global Amlodipine Besylate Price (USD/Unit) by Application (2019-2024)
Table 69. Global Amlodipine Besylate Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Amlodipine Besylate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Amlodipine Besylate Product
Table 79. Mylan Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Amlodipine Besylate Product
Table 89. Apotex Recent Developments/Updates
Table 90. Teva Pharmaceutical Corporation Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Amlodipine Besylate Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Amlodipine Besylate Product
Table 99. Cipla Recent Developments/Updates
Table 100. Hikma Pharmaceuticals Corporation Information
Table 101. Hikma Pharmaceuticals Description and Business Overview
Table 102. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 104. Hikma Pharmaceuticals Recent Developments/Updates
Table 105. Strides Pharma Corporation Information
Table 106. Strides Pharma Description and Business Overview
Table 107. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Strides Pharma Amlodipine Besylate Product
Table 109. Strides Pharma Recent Developments/Updates
Table 110. Upsher-Smith Laboratories Corporation Information
Table 111. Upsher-Smith Laboratories Description and Business Overview
Table 112. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 114. Upsher-Smith Laboratories Recent Developments/Updates
Table 115. InvaGen Pharmaceuticals Corporation Information
Table 116. InvaGen Pharmaceuticals Description and Business Overview
Table 117. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 119. InvaGen Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sun Pharmaceutical Amlodipine Besylate Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Aurobindo Pharma Amlodipine Besylate Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Lupin Pharmaceuticals Corporation Information
Table 131. Lupin Pharmaceuticals Description and Business Overview
Table 132. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 134. Lupin Pharmaceuticals Recent Developments/Updates
Table 135. Zydus Pharmaceuticals Corporation Information
Table 136. Zydus Pharmaceuticals Description and Business Overview
Table 137. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 139. Zydus Pharmaceuticals Recent Developments/Updates
Table 140. Oxford Pharm Corporation Information
Table 141. Oxford Pharm Description and Business Overview
Table 142. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Oxford Pharm Amlodipine Besylate Product
Table 144. Oxford Pharm Recent Developments/Updates
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Wockhardt Amlodipine Besylate Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Epic Pharma Corporation Information
Table 151. Epic Pharma Description and Business Overview
Table 152. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Epic Pharma Amlodipine Besylate Product
Table 154. Epic Pharma Recent Developments/Updates
Table 155. CR Pharmaceutical Corporation Information
Table 156. CR Pharmaceutical Description and Business Overview
Table 157. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. CR Pharmaceutical Amlodipine Besylate Product
Table 159. CR Pharmaceutical Recent Developments/Updates
Table 160. Alkem Laboratories Corporation Information
Table 161. Alkem Laboratories Description and Business Overview
Table 162. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Alkem Laboratories Amlodipine Besylate Product
Table 164. Alkem Laboratories Recent Developments/Updates
Table 165. MACLEODS Corporation Information
Table 166. MACLEODS Description and Business Overview
Table 167. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. MACLEODS Amlodipine Besylate Product
Table 169. MACLEODS Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Amlodipine Besylate Distributors List
Table 173. Amlodipine Besylate Customers List
Table 174. Amlodipine Besylate Market Trends
Table 175. Amlodipine Besylate Market Drivers
Table 176. Amlodipine Besylate Market Challenges
Table 177. Amlodipine Besylate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine Besylate
Figure 2. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amlodipine Besylate Market Share by Type in 2023 & 2030
Figure 4. 2.5mg Tablets Product Picture
Figure 5. 5mg Tablets Product Picture
Figure 6. 10mg Tablets Product Picture
Figure 7. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amlodipine Besylate Market Share by Application in 2023 & 2030
Figure 9. High Blood Pressure
Figure 10. Heart Disease
Figure 11. Global Amlodipine Besylate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Amlodipine Besylate Market Size (2019-2030) & (US$ Million)
Figure 13. Global Amlodipine Besylate Sales (2019-2030) & (K Units)
Figure 14. Global Amlodipine Besylate Average Price (USD/Unit) & (2019-2030)
Figure 15. Amlodipine Besylate Report Years Considered
Figure 16. Amlodipine Besylate Sales Share by Manufacturers in 2023
Figure 17. Global Amlodipine Besylate Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Amlodipine Besylate Players: Market Share by Revenue in 2023
Figure 19. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 22. North America Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 26. Europe Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 27. Germany Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2019-2030)
Figure 34. China Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 45. Latin America Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Amlodipine Besylate by Type (2019-2030)
Figure 55. Global Revenue Market Share of Amlodipine Besylate by Type (2019-2030)
Figure 56. Global Amlodipine Besylate Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Amlodipine Besylate by Application (2019-2030)
Figure 58. Global Revenue Market Share of Amlodipine Besylate by Application (2019-2030)
Figure 59. Global Amlodipine Besylate Price (USD/Unit) by Application (2019-2030)
Figure 60. Amlodipine Besylate Value Chain
Figure 61. Amlodipine Besylate Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232